EULAR 2023 | congress satellite symposia & consult the expert
A number of satellite symposia and consult the expert events will be organised during EULAR 2023, 31 May - 3 June. The Industry Programme Booklet (PDF)
Satellite symposia and Consult the Expert are governed by the EULAR Code of Practice, and are strictly prohibited during the official programme hours. All symposia and special events must be approved by EULAR.
SCHEDULE OVERVIEW*
Satellite Symposia & CTE programme overview
WEDNESDAY 31 May |
|
18:30 - 19:45 | Satellite symposia (6 parallel sessions) |
15:45 - 16:15 | Consult the Expert (3 parallel sessions) |
THURSDAY 1 JUNE |
|
08:15 - 09:30 | Satellite symposia (6 parallel sessions) |
09:45 - 10:15 | Consult the Expert (2 parallel sessions) |
15:00 - 15:30 |
Consult the Expert (3 parallel sessions) |
17:30 - 18:45 | Satellite symposia (8 parallel sessions) |
FRIDAY 2 JUNE |
|
08:15 - 09:30 | Satellite symposia (7 parallel sessions) |
09:45 - 10:15 | Consult the Expert (3 parallel sessions) |
15:00 - 15:30 | Consult the Expert (1 parallel sessions) |
17:30 - 18:45 | Satellite symposia (2 parallel sessions) |
Satellite Symposia Programme overview
31 May I 18:30 – 19:45 CEST
AbbVie - Tailor-made Care – Why Benefit: risk Assessment Should Drive Individualized Treatment Decisions
Session details
31 May I 18:30 – 19:45 CEST
Medscape Education Global (Supported by UCB) - Raising the Bar: Optimizing Outcomes in Spondylarthritis
Session details
31 May I 18:30 – 19:45 CEST
Janssen: IL-23 in PsA: connecting the domains of skin, gut, and joint
Session details
31 May I 18:30 – 19:45 CEST
GSK - Is there a “window of opportunity" in SLE?
Session details
31 May I 18:30 – 19:45 CEST
AstraZeneca - Writing a new chapter in long-term lupus care
Session details
31 May I 18:30 – 19:45 CEST
Sobi - The many faces of inflammation: which cytokine should I target, when, and why?
Session details
1 June I 08:15 – 09:30 CEST
1 June I 08:15 – 09:30 CEST
1 June I 08:15 – 09:30 CEST
1 June I 08:15 – 09:30 CEST
1 June I 08:15 – 09:30 CEST
1 June I 08:15 – 09:30 CEST
1 June I 17:30 – 18:45 CEST
1 June I 17:30 – 18:45 CEST
1 June I 17:30 – 18:45 CEST
1 June I 17:30 – 18:45 CEST
1 June I 17:30 – 18:45 CEST
1 June I 17:30 – 18:45 CEST
Galapagos - JAK to reality: seeking clarity in RA
1 June I 17:30 – 18:45 CEST
Celltrion Healthcare -
1 June I 17:30 – 18:45 CEST
Vifor -
2 June I 08:15 – 09:30 CEST
Pfizer - Unpacking the data: who are the appropriate patients with RA for a JAK inhibitor?
Session details
2 June I 08:15 – 09:30 CEST
2 June I 08:15 – 09:30 CEST
2 June I 08:15 – 09:30 CEST
2 June I 08:15 – 09:30 CEST
Roche -
2 June I 08:15 – 09:30 CEST
2 June I 08:15 – 09:30 CEST
Kyverna - CAR T Cell Therapy in B Cell Driven Autoimmune Diseases
2 June I 17:30 – 18:45 CEST
2 June I 17:30 – 18:45 CEST
Consult the expert Programme overview
31 May I 15:45 – 16:15 CEST
Boehringer Ingelheim – “Monitoring and management of lung fibrosis in patients with autoimmune diseases”
Session details
31 May I 15:45 – 16:15 CEST
GSK - Raising ambitions with clinical remission in EGPA
31 May I 15:45 – 16:15 CEST
Vifor -
1 June I 09:45 – 10:15 CEST
1 June I 09:45 – 10:15 CEST
GSK -
1 June I 15:00 – 15:30 CEST
1 June I 15:00 – 15:30 CEST
1 June I 15:00 – 15:30 CEST
GSK -
2 June I 09:45 – 10:15 CEST
Janssen - What would you do? An interactive discussion on PsA scenarios
Session details
2 June I 09:45 – 10:15 CEST
Galapagos - Burning questions: the practical use of JAK inhibitors in RA
Session details
2 June I 09:45 – 10:15 CEST
Vifor -
2 June I 15:00 – 15:30 CEST
AstraZeneca - Treat to Target: how biologics can help?
* CEST (Central European Summer time)